DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Bharti Life Insurance Company Limited — NOC/No dues certificate/consent/permission

NSE 14 hrs ago·20 Jul 2026, 1:48 pm

Company NSE

Bharti Life Insurance Company has received a formal communication from Axis Trustee Services regarding a No Objection Certificate (NOC). This document is a standard regulatory requirement that confirms the company has no outstanding dues or unresolved issues with its trustee. The NOC is specifically for the financial year 2026-2027 and relates to the company's securities with the ISIN code INE089J08037.

For investors, this update is a routine administrative step rather than a major market event. It indicates that the company is in good standing with its key service providers and is proceeding with its standard compliance procedures. This clarity helps ensure that the company's operations and regulatory filings remain on track for the upcoming fiscal period.

Investors should view this as a neutral operational update. The focus for now remains on the company's future business performance and product launches. Traders should keep an eye on the company's official announcements for any other significant developments that might impact its share price in the near term.